Lung Endothelial Aß in infectious proteinopathy
Lung Endothelial Aß in infectious proteinopathy
批准号:
10650303
负责人:
Troy Stevens
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-06-30
关键词:
Abeta synthesisAddressAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorBacteriaCRISPR/Cas technologyCellsCharacteristicsClinical ResearchCritical IllnessCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic GMPCyclic NucleotidesCytoprotectionCytotoxinDataDeath RateEndothelial CellsEndotheliumFunctional disorderGTPase-Activating ProteinsGenerationsHospitalsInfectionIntensive Care UnitsKnowledgeLength of StayLungMembraneMethylationMicroRNAsMorbidity - disease rateMultiprotein ComplexesNosocomial pneumoniaOrganPatientsPhosphorylationPlayPrionsProcessProductionPropertyProtein KinaseProteinsPseudomonas aeruginosaPseudomonas aeruginosa infectionPublishingReportingRoleSeveritiesSpecificityTestingType III Secretion System PathwayVascular EndotheliumVirulence Factorsantimicrobialbeta secretasebeta-site APP cleaving enzyme 1cell injurycytotoxiccytotoxicityenzyme activityexoenzymegamma secretasemortalitypathogenpresenilin-1preventprion-likeprotein Bprotein expressionprotein functionsequential proteolysistranscriptome sequencing
中文摘要
项目摘要/摘要
引起医院获得性肺炎的病原体会引起肺内皮细胞淀粉样蛋白的产生。这些
淀粉样蛋白可以具有抗菌特性,对宿主有益,也可以具有细胞毒性特性
对寄主不利。在后一种情况下,内皮源性淀粉样蛋白可能对终末器官有贡献
危重疾病后的功能障碍。细菌毒力因子,如假单胞菌
铜绿假单胞菌III型分泌系统效应器,最显著的是外酶Y,转化内皮淀粉样蛋白
从抗菌物质到细胞毒性物质。淀粉样β蛋白(Aβ)是一种细胞毒性淀粉样蛋白
内皮细胞感染。β从内皮细胞中释放出来,在那里它成为可传播和自我复制的
普恩细胞毒素。我们的初步数据显示,γ-分泌酶激活蛋白在
产生细胞毒性的A-β。我们发现γ-分泌酶激活蛋白在内皮细胞中的表达
偏置微阵列、RNAseq、甲基化和miRNA筛选,并确认蛋白质表达和功能
在微血管内皮细胞。γ-分泌酶激活蛋白缺失阻止细胞毒素Aβ的形成
物种。相反,在γ分泌酶激活蛋白缺失后,铜绿假单胞菌-和
胞外酶Y诱导的A-β具有抗菌特性。外切酶Y是一种杂乱的核苷酸环化酶
导致蛋白激酶A激活,这可能使Aβ磷酸化,从而增加其细胞毒活性。
这些数据表明,细胞毒性Aβ的产生是由于两种相互关联的机制,包括
γ-分泌酶激活蛋白的功能和A-β一旦产生就被磷酸化。因此,这项提议
验证外酶Y依赖于β分泌酶促进细胞毒素Aγ产生的假说
激活蛋白质。
英文摘要
PROJECT SUMMARY/ABSTRACT
Pathogens responsible for nosocomial pneumonia elicit production of lung endothelial cell amyloids. These
amyloids can have antimicrobial properties and be beneficial to the host, or they can have cytotoxic properties
and be detrimental to the host. In the latter case, endothelial-derived amyloids may contribute to end organ
dysfunction in the aftermath of critical illness. Bacterial virulence factors, such as the Pseudomonas
aeruginosa type III secretion system effectors, and most notably exoenzyme Y, convert endothelial amyloids
from antimicrobial to cytotoxic species. Amyloid-beta (Aβ) is one of the cytotoxic amyloids generated following
endothelial infection. Aβ is released from endothelium where it becomes a transmissible and self-replicating
prion cytotoxin. Our preliminary data reveals that γ-secretase activating protein plays a critical role in
generating cytotoxic Aβ. We found γ-secretase activating protein expression in endothelial cells using non-
biased microarray, RNAseq, methylation and miRNA screens, and confirmed protein expression and function
in microvascular endothelium. γ-secretase activating protein deletion prevented formation of the cytotoxic Aβ
species. Rather, following γ-secretase activating protein deletion the Pseudomonas aeruginosa- and
exoenzyme Y-induced Aβ had antimicrobial properties. Exoenzyme Y is a promiscuous nucleotidyl cyclase that
results in protein kinase A activation, which may phosphorylate Aβ necessary to increase its cytotoxic activity.
These data suggest production of cytotoxic Aβ is due to two inter-related mechanisms, including an increase in
γ-secretase activating protein function and the phosphorylation of Aβ once it is produced. Hence, this proposal
tests the hypothesis that exoenzyme Y promotes the production of cytotoxic Aβ, dependent upon γ-secretase
activating protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Soluble adenylyl cyclases in lung endothelial tauopathy
-
批准号:10636060
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2023
-
负责人:Troy Stevens
-
依托单位:
Lung Endothelial Aß in infectious proteinopathy
-
批准号:10438793
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2020
-
负责人:Troy Stevens
-
依托单位:
Lung Endothelial Aß in infectious proteinopathy
-
批准号:10207758
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2020
-
负责人:Troy Stevens
-
依托单位:
Lung Endothelial Cell Phenotypes
-
批准号:7822683
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2009
-
负责人:Troy Stevens
-
依托单位:
cAMP in Enothelial Permeability
-
批准号:7217671
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2006
-
负责人:Troy Stevens
-
依托单位:
Administrative Core
-
批准号:7217675
-
项目类别:
-
资助金额:$17.23万
-
财政年份:2006
-
负责人:Troy Stevens
-
依托单位:
Cell Culture and Microscopy
-
批准号:7217676
-
项目类别:
-
资助金额:$24.69万
-
财政年份:2006
-
负责人:Troy Stevens
-
依托单位:
Determinants of Pulmonary Endothelial Cell Function Conf
-
批准号:6707800
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2004
-
负责人:Troy Stevens
-
依托单位:
Training in Cell Signaling and Lung Pathobiology
-
批准号:9061755
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2004
-
负责人:Troy Stevens
-
依托单位:
Training in Cell Signaling and Lung Pathobiology
-
批准号:8607821
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2004
-
负责人:Troy Stevens
-
依托单位:
Training in Cell Signaling and Lung Pathobiology
-
批准号:8788713
-
项目类别:
-
资助金额:$20.92万
-
财政年份:2004
-
负责人:Troy Stevens
-
依托单位:
Calcium Inhibition of cAMP in Endothelial Cell Permeability
-
批准号:6631289
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2002
-
负责人:Troy Stevens
-
依托单位:
Cell Culture and Microscopy
-
批准号:8112465
-
项目类别:
-
资助金额:$35.26万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
Cell Culture and Microscopy
-
批准号:7897856
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
Lung Endothelial Cell Phenotypes
-
批准号:7656675
-
项目类别:
-
资助金额:$154.36万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
Lung Endothelial Cell Phenotypes
-
批准号:8267773
-
项目类别:
-
资助金额:$183.84万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
Lung Endothelial Cell Phenotypes
-
批准号:8653978
-
项目类别:
-
资助金额:$180.16万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
Lung endothelial cell phenotypes
-
批准号:10197998
-
项目类别:
-
资助金额:$203.05万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
Lung Endothelial Cell Phenotypes
-
批准号:7457927
-
项目类别:
-
资助金额:$172.62万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
Cell Culture and Microscopy
-
批准号:7656673
-
项目类别:
-
资助金额:$27.93万
-
财政年份:2001
-
负责人:Troy Stevens
-
依托单位:
海外基金